Tag : natalizumab

Neurology

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks

Newsemia
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal...
Neurology

Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation.

Newsemia
Related Articles Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation. Mult Scler Relat Disord. 2019 Nov 05;38:101498 Authors: Mustonen...
Pharma / Biotech

Pharmacokinetics and pharmacodynamics of natalizumab in pediatric patients with RRMS.

Newsemia
Related Articles Pharmacokinetics and pharmacodynamics of natalizumab in pediatric patients with RRMS. Neurol Neuroimmunol Neuroinflamm. 2019 Sep;6(5): Authors: Ghezzi A, Comi G, Grimaldi LM, Moiola...
Neurology

The real-world effectiveness of natalizumab and fingolimod in relapsing-remitting multiple sclerosis. An Italian multicentre study.

Newsemia
Related Articles The real-world effectiveness of natalizumab and fingolimod in relapsing-remitting multiple sclerosis. An Italian multicentre study. Mult Scler Relat Disord. 2019 May 31;33:146-152 Authors:...
Latest News

Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis

Newsemia
John, N; Carroll, A; Brownlee, WJ; Chataway, J; (2019) Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis. [Letter]. Journal of Neurology, Neurosurgery...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World